A Study of AK130 in Combination With AK112 for the Treatment of Advanced Biliary Tract Cancer

Clinical trial NCT06938321 · RECRUITING

Trial details

NCT number: NCT06938321
Sponsor: Akeso
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Biliary Tract Cancer

Start date: 2025-04-30
Primary completion: 2027-05-01
Enrollment: 135

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.